UMB Bank n.a. Purchases 552 Shares of Cytokinetics, Incorporated (NASDAQ:CYTK)
UMB Bank n.a. grew its holdings in Cytokinetics, Incorporated (NASDAQ:CYTK – Free Report) by 91.4% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 1,156 shares of the biopharmaceutical company’s stock after buying an additional 552 shares during the quarter. UMB Bank n.a.’s […]
UMB Bank n.a. grew its holdings in Cytokinetics, Incorporated (NASDAQ:CYTK – Free Report) by 91.4% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 1,156 shares of the biopharmaceutical company’s stock after buying an additional 552 shares during the quarter. UMB Bank n.a.’s […]
-logo.png?v=20221109115655&w=240&h=240&zc=2){kind=logo}
